Paul J. Clancy, Executive VP and CFO at BIOGEN IDEC INC. (BIIB), sold 568 shares at $50.66 ($29K) on 2008-08-08, disclosed to the SEC on 2008-08-11.
Scheduled sale ($29k) by Executive VP and CFO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.66 | 368 | $19K | 64.8% |
| 2 | $50.67 | 200 | $10K | 35.2% |
| Total | $50.66 avg | 568 | $29K | 100% |
| Filing → |
| ALXN | SELL | 2018-02-08 | $1.4M | — | Filing → |
| BIIB | SELL | 2017-04-27 | $2.9M | — | Filing → |
| BIIB | SELL | 2017-03-14 | $5.8M | — | Filing → |